{"id":"W4406536614","doi":"10.1038/s41591-024-03462-0","title":"Tucatinib and trastuzumab in HER2-mutated metastatic breast cancer: a phase 2 basket trial","year":2025,"lang":"en","type":"article","venue":"Nature Medicine","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"FUJIFILM Toyama Chemical; Bayer Yakuhin; MSD K.K.; Chugai Pharmaceutical; Eli Lilly Japan; Sierra Oncology; Sirtex Medical; Ono Pharmaceutical; Astellas Pharma; Swedish Orphan Biovitrum; Celgene; Yakult Honsha; Amgen; Coherus Biosciences; FibroGen; Puma Biotechnology; Seagen; Relay Therapeutics; Daiichi Sankyo Europe; European Society for Medical Oncology; Agios Pharmaceuticals; Veracyte; Foundation Medicine; GlaxoSmithKline; Advanced Accelerator Applications; BeiGene; PharmaMar; Array BioPharma; Nihon Medi-Physics; Clovis Oncology; Genentech; AstraZeneca; Novocure; Natera; Regeneron Pharmaceuticals; G1 Therapeutics; Lantheus Medical Imaging; Merck KGaA; Gilead Sciences; Taiho Pharmaceutical; Sumitomo Dainippon Pharma Oncology; Ipsen; Pancreatic Cancer Action Network; Mirati Therapeutics; Handok; F. Hoffmann-La Roche; Eisai; National Cancer Institute; Fondazione Beretta; Incyte; Servier; Halozyme; Exelixis; Apollomics; Sanofi; Miyarisan Pharmaceutical; Aptitude Health; Eli Lilly and Company; Bristol-Myers Squibb; Yuhan; Spectrum Pharmaceuticals; Pfizer","keywords":"Trastuzumab; Oncology; Metastatic breast cancer; Breast cancer; Medicine; Internal medicine; Clinical trial; Cancer; Cancer research","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001163766,0.0002887468,0.0009020498,0.0006964254,0.00006245454,0.00001542143,0.0001827299,0.0002702662,0.001379018],"category_scores_gemma":[0.001047384,0.0002087191,0.00005949955,0.001631442,0.0003456517,0.0000591709,0.00005612855,0.00186226,0.000006386437],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004686438,"about_ca_system_score_gemma":0.001166616,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001312141,"about_ca_topic_score_gemma":0.0005008324,"domain_scores_codex":[0.9973515,0.0002077459,0.0005944872,0.0005610833,0.0007693484,0.0005158757],"domain_scores_gemma":[0.9986211,0.0003467799,0.0000892398,0.0004084196,0.0002358082,0.000298636],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.1567535,0.003816995,0.01641679,0.003683519,0.001021055,0.002120523,0.004331757,0.000005374294,0.01480826,0.001078745,0.1638068,0.6321567],"study_design_scores_gemma":[0.7851263,0.006384556,0.06551762,0.00951138,0.001332002,0.0008015751,0.002802571,0.002055564,0.00359543,0.001205799,0.1209214,0.00074588],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8800324,0.01950289,0.00004741489,0.09005031,0.001389068,0.002721634,0.0001321055,0.000102681,0.006021548],"genre_scores_gemma":[0.9916055,0.001176629,0.0001706525,0.003868754,0.0006374581,0.0002884827,0.00007989705,0.0000358618,0.002136833],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6314109,"threshold_uncertainty_score":0.9995338,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02580338968397959,"score_gpt":0.4717154380101767,"score_spread":0.4459120483261971,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}